Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and
amyotrophic lateral sclerosis, comprise a family of disorders characterized by progressive …

Hepatitis C virus (HCV) infection is responsible for both hepatic and extra-hepatic disorders
(HCV-EHDs); these latter are correlated on one hand clearly with HCV lymphotropism …

Hepatitis C virus (HCV) infection is widespread and affects 71 million people worldwide.
Although hepatic manifestations are the most frequent, ranging from chronic hepatitis to …

Chronic hepatitis C virus (HCV) infection poses a remarkable burden on the health care
system worldwide because of an estimated prevalence of about 3% 1 and association with …

Objectives Age-related physiological changes, particularly immune system decline, may
contribute to greater vulnerability to infectious diseases in older individuals. A growing body …

Several foreign antigens such as those derived from viruses and bacteria have been linked
to long-term deleterious effects on the brain and other organs; yet, health outcomes …

Hepatic encephalopathy (HE) is a neuropsychiatric syndrome of both acute and chronic liver
disease. As a metabolic disorder, HE is considered to be reversible and therefore is …

Obesity and diabetes are strongly associated not only with fatty liver but also cognitive
dysfunction. Moreover, their presence, particularly in midlife, is recognized as a risk factor for …

Background and aim Treatment of hepatitis C with direct-acting antiviral agents (DAA) has
few side effects. Although pivotal studies suggested that DAA were safe in patients with …

The hepatitis C virus (HCV) causes serious issues, affecting 71 million people globally. The
most common manifestations range from chronic hepatitis to liver cirrhosis, leading to …